IL15 and neoplasm: All CAR constructs used in this study are based on a second-generation CAR designed with 4-1BB as an intracellular costimulatory domain, and all expanded or quiescent CAR T cells were conditioned with human IL-7 and IL-15 post-EP or -LNP and prior to coculture with tumor cells.